Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  European Journal of Heart Failure

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/s1388-9842(01)00174-xPMID 11511434
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical trials update: highlights of the scientific sessions of the American Heart Association year 2000: Val HeFT, COPERNICUS, MERIT, CIBIS‐II, BEST, AMIOVIRT, V‐MAC, BREATHE, HEAT, MIRACL, FLORIDA, VIVA and the first human cardiac skeletal muscle myoblast transfer for heart failure

  2001cited by this paper
• beta-adrenergic receptor blockade in chronic heart failure.

  2000cited by this paper
• Beta-blockers for congestive heart failure: what is the current consensus?

  2000cited by this paper
• A rationale for the use of beta-blockers as standard treatment for heart failure.

  2000cited by this paper
• Is the prognosis of heart failure improving?

  2000cited by this paper
• Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

  2000cited by this paper
• The treatment and prevention of coronary heart disease in Canada: do older patients receive efficacious therapies? The Clinical Quality Improvement Network (CQIN) Investigators.

  1999cited by this paper
• Has the survival of the heart failure population changed? Lessons from trials.

  1999cited by this paper
• Consensus recommendations for the management of chronic heart failure. On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure.

  1999cited by this paper
• The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.

  1999cited by this paper
• Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

  1999cited by this paper
• Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators.

  1999cited by this paper
• Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

  1999cited by this paper
• Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction.

  1998cited by this paper
• Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting Enzyme.

  1998cited by this paper
• The effect of digoxin on mortality and morbidity in patients with heart failure.

  1997cited by this paper
• Rationale for treatment of patients with chronic heart failure with adrenergic blockade.

  1996cited by this paper
• Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure.

  1996cited by this paper
• The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

  1996cited by this paper
• Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]).

  1996cited by this paper
• Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

  1991cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper
• EDEMA AND DECREASED RENAL BLOOD FLOW IN PATIENTS WITH CHRONIC CONGESTIVE HEART FAILURE: EVIDENCE OF "FORWARD FAILURE" AS THE PRIMARY CAUSE OF EDEMA.

  1946cited by this paper

• Molecular Mechanisms Underlying Heart Failure and Their Therapeutic Potential

  2025cites this paper
• Polypharmacy in older patients with diabetes mellitus: a population based-study of northern Italy

  2025cites this paper
• Optimizing Cardiovascular Outcomes With Bisoprolol: An Evidence-Based Perspective

  2025influential citation
• Frailty and Its Implications in Heart Failure with Reduced Ejection Fraction: Impact on Prognosis and Treatment.

  2024cites this paper
• Efficacy of Guideline-Directed Medical Therapy in Heart Failure Patients With and Without Chronic Kidney Disease: A Meta-Analysis of 63,677 Patients.

  2024cites this paper
• Diabetes mellitus in patients with heart failure and effect modification of risk factors for short-term mortality: An observational study from the Registro Colombiano de Falla Cardíaca (RECOLFACA)

  2024cites this paper
• Update on clinical and experimental management of diabetic cardiomyopathy: addressing current and future therapy

  2024cites this paper
• Herzinsuffizienz bei Patienten mit Diabetes mellitus

  2024cites this paper
• Incremental prognostic value of functional impairment assessed by 6-min walking test for the prediction of mortality in heart failure

  2024cites this paper
• Understanding Heart Failure: Evolution of Concepts and Treatments

  2024cites this paper
• Rethinking the Impact and Management of Diabetes in Heart Failure Patients

  2023cites this paper
• The treatment of chronic anemia in heart failure: a global approach

  2023cites this paper
• 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.

  2023cites this paper
• Frailty and Its Implications in Heart Failure with Reduced Ejection Fraction: Impact on Prognosis and Treatment.

  2023cites this paper
• (Pharmacotherapy of chronic heart failure from the viewpoint of the new ESC 2021 guidelines)

  2022cites this paper
• The Association between Beta-Blocker and Renin Angiotensin System Inhibitor Use After HFrEF Hospitalization and Outcomes in Older Patients.

  2022cites this paper
• Positionspapier Herzinsuffizienz und Diabetes

  2022cites this paper
• Cellular mechanisms and recommended drug-based therapeutic options in diabetic cardiomyopathy.

  2021cites this paper
• The association between neurohormonal therapy and mortality in older adults with heart failure with reduced ejection fraction

  2021cites this paper
• Therapeutic Properties of Highly Selective β-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease

  2021cites this paper
• Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure

  2021cites this paper
• Herzinsuffizienz bei Menschen mit Diabetes mellitus

  2021cites this paper
• Heart Failure in Patients with Diabetes and Chronic Kidney Disease: Challenges and Opportunities

  2021cites this paper
• The use of β-blockers in patients with heart failure and comorbidities: Doubts, certainties and unsolved issues.

  2021cites this paper
• Heart failure in diabetes mellitus: an updated review.

  2020cites this paper
• Guía ESC 2019 sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes (EASD)

  2020cites this paper
• Management of heart failure and type 2 diabetes mellitus: Maximizing complementary drug therapy

  2020cites this paper
• Left-sided heart disease and risk of death in patients with end-stage kidney disease receiving haemodialysis: an observational study

  2020cites this paper
• Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America.

  2019cites this paper
• 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.

  2019cites this paper
• Treatment of Patients with Heart failure and Type 2 Diabetes: a review of the literature

  2019cites this paper
• Terapia farmacologica dello scompenso cardiaco cronico nell ’ anziano

  2019cites this paper
• MANAGEMENT OF HEART FAILURE IN PATIENTS WITH DIABETES MELLITUS : A REVIEW

  2019cites this paper
• Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America.

  2019cites this paper
• [Heart failure in patients over 80 years old].

  2019cites this paper
• Blood pressure targets for hypertension in patients with type 2 diabetes.

  2018cites this paper
• Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology

  2018cites this paper
• Korean Guidelines for Diagnosis and Management of Chronic Heart Failure

  2017cites this paper
• The effect of remote ischaemic preconditioning on contrast induced nephropathy in the clinical setting of coronary angiography and percutaneous coronary intervention

  2017cites this paper
• A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure

  2016cites this paper
• Novel insight into the dangerous connection between diabetes and heart failure

  2016cites this paper
• Pharmacological interventions for heart failure in people with chronic kidney disease.

  2016cites this paper
• Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure.

  2015cites this paper
• Concomitant diabetes mellitus and heart failure.

  2015cites this paper
• Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min).

  2015cites this paper
• Review of heart failure treatment in type 2 diabetes patients: It's at least as effective as in non-diabetic patients!

  2015cites this paper
• Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis.

  2015cites this paper
• Management of Noncardiac Comorbidities in Chronic Heart Failure.

  2015cites this paper
• The Effects of Comorbidity on the Benefits and Harms of Treatment for Chronic Disease: A Systematic Review

  2014cites this paper
• Of heart and kidney: a complicated love story

  2014cites this paper
• Implications of Kidney Disease in the Cardiac Patient.

  2014cites this paper
• KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.

  2014cites this paper
• Comparative effectiveness research in heart failure therapies: women, elderly patients, and patients with kidney disease.

  2013cites this paper
• Medication Management of Chronic Heart Failure in Older Adults

  2013cites this paper
• Effectiveness of β-blockers in heart failure with left ventricular systolic dysfunction and chronic kidney disease.

  2013cites this paper
• [Advantages of quinapril therapy in patients with arterial hypertension and functional class III chronic heart failure with preserved left ventricular ejection fraction].

  2012cites this paper
• [Safety of β-blockers. Prejudices and reality].

  2012cites this paper
• Chapter 4: Other complications of CKD: CVD, medication dosage, patient safety, infections, hospitalizations, and caveats for investigating complications of CKD

  2012cites this paper
• Sub-Types and Therapeutic Management of the Cardiorenal Syndrome

  2012cites this paper
• Influence of patient age and comorbid burden on clinician attitudes toward heart failure guidelines.

  2012cites this paper
• Chapter 5: Referral to specialists and models of care

  2012cites this paper
• Early detection of CKD: the benefits, limitations and effects on prognosis

  2011cites this paper
• Heart failure treatment in the elderly

  2011cites this paper
• Age and Receipt of Guideline-Recommended Medications for Heart Failure: A Nationwide Study of Veterans

  2011cites this paper
• Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).

  2011cites this paper
• Efficacy and Safety of Carvedilol in Treatment of Heart Failure with Chronic Kidney Disease: A Meta-Analysis of Randomized Trials

  2011cites this paper
• Effects of Beta-Adrenergic Antagonists in Patients With Chronic Kidney Disease

  2011cites this paper
• β blockers for heart failure with reduced ejection fraction

  2011cites this paper
• Heart Failure among Older Home Care Clients: An Examination of Client Needs, Medication Use and Outcomes

  2011cites this paper
• Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis.

  2011cites this paper
• Heart failure in subjects with chronic kidney disease: Best management practices.

  2010cites this paper
• Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure

  2010cites this paper
• Cardiorenal syndromes--recommendations from clinical practice guidelines: the cardiologist's view.

  2010cites this paper
• Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS‐II) trial

  2010cites this paper
• Pharmacologic management of patients with both heart failure and diabetes

  2009cites this paper
• The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF).

  2009influential citation
• Pharmacologic therapy in patients with chronic heart failure and chronic kidney disease: a complex issue

  2009cites this paper
• Optimal management of chronic heart failure in patients with chronic kidney disease.

  2009cites this paper
• Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial

  2009cites this paper
• [Renal function in heart failure patients. Prognostic influence and therapeutic implications].

  2009cites this paper
• Review article: Diabetes mellitus and heart failure — an overview of epidemiology and management

  2009cites this paper
• Safety and tolerability of beta-blockers: prejudices and reality

  2009cites this paper
• Heart failure and diabetes mellitus: epidemiology and management of an alarming association.

  2008cites this paper
• Type 2 Diabetes Mellitus and Heart Failure

  2008cites this paper
• Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.

  2008cites this paper
• Long‐term outcome in diabetic heart failure patients treated with cardiac resynchronization therapy

  2008cites this paper
• Discordant Short- and Long-Term Outcomes Associated With Diabetes in Patients With Heart Failure: Importance of Age and Sex: A Population Study of 5.1 Million People in Scotland

  2008cites this paper
• Bisoprolol for congestive heart failure

  2008cites this paper
• Broken pump or leaky filter? Renal dysfunction in heart failure a contemporary review.

  2008cites this paper
• Therapies for acute heart failure in patients with reduced kidney function: a community-based perspective.

  2008cites this paper
• A review of evidence-based beta-blockers in special populations with heart failure.

  2008cites this paper
• Diabetes, left ventricular systolic dysfunction, and chronic heart failure.

  2008cites this paper
• beta-Adrenoceptor antagonists in elderly patients with heart failure: a critical review of their efficacy and tolerability.

  2007cites this paper
• Anaemia and renal function in heart failure due to idiopathic dilated cardiomyopathy

  2007cites this paper
• Bisoprolol in the treatment of chronic heart failure

  2007cites this paper
• [Importance of the study of renal function in cardiology].

  2007cites this paper
• Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results

  2007cites this paper
• Safety and efficacy of carvedilol in very elderly diabetic patients with heart failure

  2007cites this paper
• Should beta‐blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET

  2007cites this paper
• [Diabetes and heart failure, a fatal association].

  2007cites this paper